Technology

MintNeuro and Motif Neurotech Partner to Advance Miniature Brain-Computer Interface Therapy for Mental Health

Published

11 hours ago

April 30, 2026

Strategic partnership combines MintNeuro’s purpose-built neural sensing and stimulation chips with Motif’s ultra-miniaturised therapeutic implant platform — enabling precision neuromodulation and real-time response monitoring

LONDON, April 30, 2026 /PRNewswire/ — MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature implants for mental health, today announced a new strategic partnership that will unite MintNeuro’s specialised neural interface chip technology with Motif’s clinical-stage therapeutic implant platform – accelerating the clinical availability of therapeutic BCIs for mental health conditions.

The collaboration gives Motif access to MintNeuro’s highly miniaturized, purpose-built sensing and stimulation integrated circuits, with chip development closely aligned to Motif’s clinical device roadmap. With this formal alliance, MintNeuro gains a direct pathway to clinical application, including real-world system validation and a continuous feedback loop on chip requirements from one of the most demanding device programmes in the sector. The partnership is underpinned by a multi-year commercial supply agreement, securing access to MintNeuro’s neural interface ICs for Motif’s pre-clinical, early clinical, and pivotal study phases.

Motif Neurotech is developing the world’s first fully implantable brain stimulating and recording technology designed to address mental health conditions, like depression and bipolar disorder. Motif recently received FDA approval to begin a US clinical trial to treat treatment-resistant depression. The DOT, a device roughly the size of a blueberry, can be placed in a 20-minute outpatient procedure without exposing or touching the brain. MintNeuro’s compact, ultra-low-power ICs enable the critical neural sensing and stimulation functions within the system, meeting the extreme miniaturisation requirements demanded by these next-generation devices. Advanced sensing capabilities enable continuous monitoring of neural activity during therapy and may provide clinicians with rapid feedback on stimulation parameter effectiveness, and risk of relapse, laying the foundation for transformative closed-loop therapeutic approaches.

The two companies have been closely collaborating for over a year, progressing from joint system architecture definition through to active hardware validation. MintNeuro’s sensing chip has already been successfully integrated into the Motif’s devices used in pre-clinical work. Going forward, the partnership roadmap will align successive MintNeuro chip generations with Motif’s clinical development programme, beginning with high-performance sensing and advancing toward fully integrated stimulation capability.

“MintNeuro is a core technology partner for Motif as we advance delivery of our BCI device roadmap,” said Steven Goetz, Chief Technology Officer of Motif Neurotech. “MintNeuro’s specialised ICs combine compact form factor, high performance and ultra-low power. These are the leading-edge capabilities needed to achieve our shared strategic vision of delivering neuromodulation therapy to the brain with the smallest and safest devices possible.”

“Every design decision we make is ultimately about how quickly and safely we can reach patients who have run out of options. MintNeuro’s technology has already proven itself in our pre-clinical work, and formalizing this partnership means we have a chip roadmap that’s tightly coupled to our clinical program,” said Jacob Robinson, Co-Founder and CEO, Motif Neurotech.

Dorian Haci, CEO and Co-Founder of MintNeuro added: “We really value working together with Motif to deliver world-first BCI-enabled therapies. Motif is a visionary partner that is pushing the boundaries of what is technically and clinically possible in this emerging space, and that is exactly the kind of collaboration our technology is built for. Our formal co-operation is also a clear signal that the treatment of mental health conditions is moving into a phase where scalable, chip-based platforms can start to be applied commercially at scale, and play a central role in enabling new therapies that can improve quality of life for patients everywhere.”

The partnership builds on successful project grants awarded to both companies as part of the UK government’s Advanced Research and Invention Agency (ARIA) Precision Neurotechnologies programme. The Brain Mesh project, a £4.7 million collaboration involving teams from both MintNeuro and Motif Neurotech, is developing distributed networks of ultra-small wireless neural implants for mental health applications. The ground-breaking work achieved under the project framework has accelerated MintNeuro’s chip miniaturisation roadmap and led Motif to establish a UK subsidiary that employs UK-based software engineers and data scientists that can work more closely with their UK partners.

Notes to editors

About MintNeuro (www.mintneuro.com)

Founded as a spinout from Imperial College London, MintNeuro is a semiconductor company focused exclusively on advanced integrated circuits for neural implants. The company designs purpose-built, low-power sensing and stimulation ICs that enable medical device developers to build smaller, smarter, and more capable implantable systems. MintNeuro’s modular chip platform addresses applications across neurology and mental health, including epilepsy, movement disorders, depression, and cognitive conditions. With a robust intellectual property portfolio and strategic partnerships with leading research institutions and neurotech companies, MintNeuro is at the forefront of the emerging neural implant and brain-computer interface sectors.

About Motif Neurotech (www.motifneuro.tech)

Motif Neurotech is building the world’s first therapeutic brain-computer interface (BCI) to treat drug-resistant mental health conditions. The company’s first product, the DOT, is a blueberry sized implantable neural device delivered in a 20-minute outpatient procedure and does not contact or expose the brain. The extreme miniaturisation of the device is made possible by patented wireless power technology invented at Rice University by the founders and exclusively licensed by Motif. The company received FDA approval in April 2026 to begin a clinical trial for treatment-resistant depression, and is also exploring applications in other neuropsychiatric conditions. Since its founding in 2022, Motif has raised over $30M in venture capital from Arboretum, KdT, and Dolby Family Ventures, and non-dilutive funding from ARIA, DARPA, ARPAH, and the NIH.

View original content:https://www.prnewswire.co.uk/news-releases/mintneuro-and-motif-neurotech-partner-to-advance-miniature-brain-computer-interface-therapy-for-mental-health-302758669.html

Technology

Brightstar Lottery Receives Highest MSCI ESG Rating of AAA

Published

8 minutes ago

April 30, 2026

LONDON, April 30, 2026 /PRNewswire/ — Brightstar Lottery PLC (NYSE: BRSL) (“Brightstar”) announced that it received the highest MSCI ESG rating of AAA. This rating exemplifies Brightstar’s commitment to global sustainability leadership in managing ESG-related risks and opportunities. Brightstar received a perfect score for carbon emissions and high scores in the product safety and quality category.

“Receiving the MSCI AAA ESG rating in Brightstar’s first year as a pure-play lottery company highlights our commitment to making sustainability practices a priority throughout our business,” said Wendy Montgomery, Brightstar SVP, Branding, Communications and Sustainability. “This rating from MSCI serves as motivation to continue our work building a sustainable future where our people, our partners, and our planet can thrive.”

MSCI ESG Ratings measure a company’s resilience to long-term, industry-specific sustainability risks using a rules-based methodology. MSCI analysts research and rate companies on a ‘AAA’ (leader) to ‘CCC’ (laggard) scale based on their exposure to and management of these risks relative to peers.

MSCI Sustainability and Climate products and services are provided by MSCI Solutions LLC and certain related entities, and are designed to provide in-depth research, ratings and analysis of environmental, social and governance related business practices to companies worldwide. ESG ratings, data and analysis from MSCI Sustainability and Climate are also used in the construction of MSCI Indexes.

Brightstar received its MSCI ESG rating on March 23, 2026.

About Brightstar Lottery PLC
Brightstar Lottery PLC (NYSE: BRSL) is a global leader in lottery focused on innovation and forward-thinking strategies and solutions, building on our renowned expertise in delivering secure technology and producing reliable, comprehensive solutions for our customers. As a premier pure play global lottery company, our best-in-class lottery operations, retail and digital solutions, and award-winning lottery games enable our customers to achieve their goals, entertain players and distribute meaningful benefits to communities. Brightstar has a well-established local presence and is a trusted partner to governments and regulators around the world, creating value by adhering to the highest standards of service, integrity, and responsibility. Brightstar serves nearly 90 lottery customers and their players on six continents. It is the primary technology provider to 26 of the 46 lottery jurisdictions in the U.S. and eight of the world’s 10 largest lotteries. Brightstar has approximately 6,000 employees. For more information, please visit www.brightstarlottery.com or follow along on LinkedIn.

Cautionary Statement Regarding Forward-Looking Statements
This news release may contain forward-looking statements (including within the meaning of the Private Securities Litigation Reform Act of 1995) concerning Brightstar Lottery PLC and its consolidated subsidiaries and other matters. These statements may discuss goals, intentions, and expectations as to future plans, trends, events, products and services, customer relationships, results of operations, or financial condition, or otherwise, including specific sustainability goals, based on current beliefs of the management of the Company as well as assumptions made by, and information currently available to, such management. Forward-looking statements may be accompanied by words such as “aim,” “anticipate,” “believe,” “plan,” “could,” “would,” “should,” “shall,” “continue,” “estimate,” “expect,” “forecast,” “future,” “guidance,” “intend,” “may,” “will,” “possible,” “potential,” “predict,” “project” or the negative or other variations of them. These forward-looking statements speak only as of the date on which such statements are made and are subject to various risks and uncertainties, many of which are outside the Company’s control. Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may differ materially from those predicted in the forward-looking statements and from past results, performance, or achievements. Therefore, you should not place undue reliance on such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include (but are not limited to) macroeconomic, regulatory and political uncertainty, including as a result of new or increased tariffs, trade wars, and other restrictions on trade between or among countries in which the Company operates, and related changes in discretionary consumer spending and behavior, fluctuations in foreign currency exchange rates, and the other factors and risks described in the Company’s most recent annual report on Form 20-F and other documents filed or furnished from time to time with the SEC, which are available on the SEC’s website at www.sec.gov and on the investor relations section of the Company’s website at www.brightstarlottery.com. Except as required under applicable law, the Company does not assume any obligation to update these forward-looking statements. You should carefully consider these factors and other risks and uncertainties that may affect the Company’s business. All forward-looking statements contained in this news release are qualified in their entirety by this cautionary statement. All subsequent written or oral forward-looking statements attributable to the Company, or persons acting on its behalf, are expressly qualified in their entirety by this cautionary statement.

Contact:
Mike DeAngelis, Corporate Communications, +1 (401) 392-1000, mike.deangelis@brightstarlottery.com
Matteo Selva, Italian media inquiries, +39 366 6803635
James Hurley, Investor Relations, +1 (401) 392-7190

The trademarks and/or service marks used herein are either trademarks or registered trademarks of Brightstar Lottery PLC, its affiliates or its licensors.

View original content to download multimedia:https://www.prnewswire.com/news-releases/brightstar-lottery-receives-highest-msci-esg-rating-of-aaa-302757947.html

SOURCE Brightstar Lottery PLC

Technology

CNFinance Files Annual Report on Form 20-F for Fiscal Year 2025

Published

8 minutes ago

April 30, 2026

GUANGZHOU, China, April 30, 2026 /PRNewswire/ — CNFinance Holdings Limited (NYSE: CNF) (“CNFinance” or the “Company”), a leading home equity loan service provider in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on April 30, 2026.

The annual report can be accessed on the Company’s investor relations website at http://ir.cashchina.cn as well as the SEC’s website at http://www.sec.gov.

The Company will provide a hard copy of its annual report, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company’s IR Department at ir@cashchina.cn.

About CNFinance Holdings Limited

CNFinance Holdings Limited (NYSE: CNF) (“CNFinance” or the “Company”) is a leading home equity loan service provider in China. CNFinance, through its operating subsidiaries in China, conducts business by connecting demands and supplies through collaborating with sales partners and trust companies under the trust lending model, and sales partners, local channel partners and commercial banks under the commercial bank partnership model. Sales partners and local channel partners are responsible for recommending micro- and small-enterprise (“MSE”) owners with financing needs to the Company and the Company introduces eligible borrowers to licensed financial institutions with sufficient funding sources including trust companies and commercial banks who will then conduct their own risk assessments and make credit decisions. The Company’s primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities and other major cities in China. The Company’s risk mitigation mechanism is embedded in the design of its loan products, supported by an integrated online and offline process focusing on risks of both borrowers and collateral and further enhanced by effective post-loan management procedures.

View original content:https://www.prnewswire.com/news-releases/cnfinance-files-annual-report-on-form-20-f-for-fiscal-year-2025-302758594.html

SOURCE CNFinance Holdings Limited

Technology

Abram’s Kaizen Program Announces 10-Year Milestone in Online Health Coaching

Published

8 minutes ago

April 30, 2026

LOS ANGELES, April 30, 2026 /PRNewswire/ — Abram’s Kaizen Program, an online health coaching program for women aged 35 and older, today announced that it has served more than 6,000 clients since its founding in 2014 and currently supports approximately 1,000 active members.

The program was founded by Abram Anderson, a nutritionist, published author and public speaker who developed the company’s methodology after investing, by his account, more than $200,000 in direct mentorship from practitioners in behaviour change, gut health and women’s hormonal health. Abram’s Kaizen Program focuses on women navigating perimenopause, menopause and postmenopause — a demographic the company says is often overlooked by mainstream weight management programs.

“A lot of women in this age group come to us after trying multiple approaches that didn’t produce the results they were looking for,” said Abram Anderson, Founder of Abram’s Kaizen Program. “Our program offers a different framework. Whether it’s the right fit depends on the individual, but the demand we’ve seen over the past decade tells us there’s a gap in the market.”

Abram’s Kaizen Program uses what the company calls a “Data-Driven Decision” methodology — an approach adapted from the Japanese manufacturing principle of kaizen, or continuous improvement. Rather than prescribing standardised meal plans, clients are guided to track how their bodies respond to specific foods. Monitoring energy levels, digestive patterns and weight fluctuations and use that information to make individualised dietary adjustments.

The program places emphasis on gut microbiome health and hormonal balance, which the company considers relevant factors in weight management for its target demographic. Research published in Frontiers in Nutrition has explored the relationship between gut microbiota composition and metabolic health, including the role of low-grade inflammation.

Program members receive access to a custom mobile application, a support chat with responses guaranteed within 24 hours, optional access to over 20 live coaching calls per week with nutritionists, a year-long curriculum, and an AI coaching assistant. “The goal is for clients to build habits they can sustain on their own,” said Abram Anderson. “We want people to eventually graduate from the program, not stay in it indefinitely.”

About Abram’s Kaizen Program

Abram’s Kaizen Program is an online health coaching program for women aged 35 and older. Founded in 2014 by nutritionist and published author Abram Anderson, the program uses a personalised, data-informed approach with a focus on gut health and hormonal balance. The program has served more than 6,000 clients and currently supports approximately 1,000 active members. For more information, visit abramskmtp.com

Media Details:

Company Name: Abram’s Kaizen Program
Founder: Abram Anderson
Email Contact: media@abramskmtp.com
Company Website: https://www.abramskmtp.com/
Location: Los Angeles, United States

Photo – https://mma.prnewswire.com/media/2964712/Abrams_Kaizen_Program.jpg

View original content:https://www.prnewswire.co.uk/news-releases/abrams-kaizen-program-announces-10-year-milestone-in-online-health-coaching-302759490.html